Last reviewed · How we verify

NCT06936397: CRT-SCHZ

Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional Regulation

Recruiting now NA Last updated 20 April 2025
What this trial tests

NA trial testing Cognitive Remediation Therapy in Schizophrenia Disorders in 60 participants. Currently enrolling.

Timeline
15 March 2025
Primary endpoint
15 August 2025
15 October 2025

Quick facts

Lead sponsorBeykoz University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date15 March 2025
Primary completion15 August 2025
Estimated completion15 October 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Beykoz University

Who can join

Adults 18 to 55, any sex, with Schizophrenia Disorders or Cognitive Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine whether Cognitive Remediation Therapy (CRT) can improve attention, memory, and emotional regulation in people with schizophrenia. CRT is a structured program that includes exercises to strengthen cognitive skills such as problem-solving, working memory, and emotion regulation. The study will recruit 60 participants: 30 individuals with schizophrenia and 30 healthy individuals of similar age and gender. Those with schizophrenia will be randomly assigned to either receive CRT or be placed on a waitlist without therapy. All participants will undergo non-invasive brain activity (EEG) and emotional response (GSR) recordings before and after the therapy. The study's main question is: Does participating in a 12-week CRT program improve brain-based markers of attention and emotional regulation in people with schizophrenia? Additional tests, such as memory and emotion recognition tasks and self-report questionnaires, will help assess changes in thinking skills and emotional well-being. The study may help better understand how CRT affects both brain function and quality of life in schizophrenia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cognitive Remediation Therapy

Trials testing the same drug.

Other recruiting trials for Schizophrenia Disorders

Currently open trials in the same condition.

Other Beykoz University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06936397.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing